Boston Scientific (BSX) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 4.26 | 2.70 | 2.98 | 2.38 | 2.38 | 1.94 | |||
Changes by years, y/y, % | -12% | -37% | +10% | -20% | 0% | -3.5% |
Boston Scientific. Debt/EBITDA
Boston Scientific. Debt/EBITDA, changes, %
Boston Scientific (BSX) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | 2.67 | 2.57 | 2.57 | 2.40 | 2.05 | 1.94 | ||
Changes by years, y/y, % | -18% | +6% | +6% | -21% | -32% | |||
Changes by quarters, q/q, % | -12% | -4% | 0% | -7% | -14% |